Home | Articles
Published on:August 2019
Indian Journal of Pharmaceutical Education and Research, 2019; 53(3s):s325-s331
Original Article | doi:10.5530/ijper.53.3s.102

Molecular Docking Studies of Novel Furan-azetidinone Hybrids as Potential Inhibitors of Escherichia coli


Authors and affiliation (s):

Judy Jays1,*, Shamanna Mohan2, Janardhanan Saravanan2

1Faculty of Pharmacy, M.S. Ramaiah University of applied sciences, M.S.R.I.T. Post, Bangalore, Karnataka, INDIA.

2PES College of Pharmacy, Hanumanthnagar, Bangalore, Karnataka, INDIA.

Abstract:

Escherichia coli is the predominant gram negative bacteria responsible for a variety of hospital-acquired infections and urinary tract infections. As the bacterial strains are rapidly acquiring resistance to the available antibiotics, there is a need to discover novel antibacterial agents with different scaffolds. In this study, sixteen novel furan derivatives containing the azetidinone moiety were designed and synthesized to arrive at potentially effective antibacterial agents. In silico antibacterial activity was carried out to identify the specificity of the furan derivatives for the antibacterial targets. Molecular docking studies were conducted on four antibacterial targets of E. coli; Dihydrofolate reductase, DNA gyrase, Enoyl reductase and methionine aminopeptidase. Energy minimization of title compounds was carried out and they were docked on to the active site of the enzymes. Ligands were ranked according to their docking scores and their binding energy with the enzyme. The results obtained for the molecular docking of the title compounds with enoyl reductase of E. coli is quite promising. The study suggests that compounds 4E and 4D are potential inhibitors of enoyl reductase and specifically bind to the enzyme.

Key words: Furan, Azetidinone, E. coli, Docking, Anti-bacterial activity.

 

Articles in PDF, ePUB and Full text are attached to this page. In order to download, print or access these formats you must be logged in.
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
16 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the 2019 Release of Journal Citation Reports (source: 2018 Web of Science Data).

 

Impact Factor® as reported in the 2018 Journal Citation Reports® (Clarivate Analytics, 2019): 0.425

User login

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
5 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs